LncRNA PCAT6 promotes progression and metastasis of colonic neuroendocrine carcinoma via MAPK pathway

Table 1 Relationship between prostate cancer associated transcript 6 expression and clinicopathologic variables of colonic neuroendocrine carcinomas

Clinical features	n	PCAT6 expression		P value
		High (16)	Low (14)
Age				0.4642
≤ 65	15	7	8
> 65	15	9	6
Gender				0.7321
Male	16	9	7
Female	14	7	7
Grade				0.5257
I-II	23	13	10
III	7	3	4
TNM
I-II	13	4	9	*0.0303
III-IV	17	12	5
Invasion depth				0.8808
T1+T2	3	2	1
T3	19	10	9
T4	8	4	4
Lymphatic metastasis				0.0281
Absent	15	5	10
Present	15	11	4
Distant metastasis
Absent	17	6	11	0.0235
Present	13	10	3
Death
Absent	14	4	10	0.0110
Present	16	12	4